Patrick Machado, Director at Adverum Biotechnologies, Inc. (ADVM), bought 10,000 shares at $9.92 ($99K) on 2021-03-24, disclosed to the SEC on 2021-03-24.
Open-market purchase of $99k ADVM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| UROV | BUY | 2019-06-14 | $355K | — | Filing → |
| UROV | BUY | 2019-06-11 | $292K | — | Filing → |
| UROV | BUY | 2019-06-06 | $218K | — | Filing → |